Tailored drug delivery reduces adverse effects after PCI

NEW ORLEANS, La., Nov. 10 - Individually tailored anti-clotting medication dosing significantly cut the rate of adverse events after non-emergent percutaneous coronary intervention (PCI) with stenting, researchers reported at the American Heart ...